# Sub-Q Bionics Closes $1.5M Pre-Seed Round Backed by Mayo Clinic and Weizmann Institute

> financing · REPORTED · 2026-03-31

Sub-Q Bionics closed a $1.5 million pre-seed round on March 31, 2026, with investment from Mayo Clinic, Yeda (the technology transfer arm of the Weizmann Institute of Science), and private investors, plus matching funds from the Israel Innovation Authority; Mayo Clinic will also collaborate on R&D activities.

About Sub-Q Bionics: Sub-Q Bionics is a Stillwater, Minnesota medical device company developing a subcutaneous implantable bionic lymph node designed to automate lymphatic fluid management for lymphedema patients, a chronic condition common in cancer survivors.

- Company: Sub-Q Bionics
- Sector: biotech
- Primary source: https://www.businesswire.com/news/home/20260330377271/en/Sub-Q-Bionics-Closes-$1.5M-Pre-Seed-Round-to-Advance-Next-Generation-Solution-for-Lymphedema-Care

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.